Jazz Pharmaceuticals PLC (JAZZ)
176.68
-2.49 -1.39%
NASDAQ
May 17, 16:59
USD
Jazz Pharmaceuticals Market Cap:
10.72B for May 17, 2021View 4,000+ financial data types
Browse...
View Full Chart
Market Cap Chart
Export Data
Save Image
Print Image
For advanced charting, view our full-featured
Fundamental Chart
Historical Market Cap Data
View and export this data going back to 2007.
Start your Free Trial
Export Data
Date Range:
| Data for this Date Range | |
|---|---|
| May 17, 2021 | 10.72B |
| May 14, 2021 | 10.87B |
| May 13, 2021 | 10.81B |
| May 12, 2021 | 10.68B |
| May 11, 2021 | 10.55B |
| May 10, 2021 | 10.69B |
| May 7, 2021 | 10.60B |
| May 6, 2021 | 10.49B |
| May 5, 2021 | 10.37B |
| May 4, 2021 | 9.115B |
| May 3, 2021 | 9.396B |
| April 30, 2021 | 9.354B |
| April 29, 2021 | 9.430B |
| April 28, 2021 | 9.396B |
| April 27, 2021 | 9.287B |
| April 26, 2021 | 9.422B |
| April 23, 2021 | 9.486B |
| April 22, 2021 | 9.530B |
| April 21, 2021 | 9.660B |
| April 20, 2021 | 9.563B |
| April 19, 2021 | 9.510B |
| April 16, 2021 | 9.609B |
| April 15, 2021 | 9.580B |
| April 14, 2021 | 9.462B |
| April 13, 2021 | 9.288B |
| April 12, 2021 | 9.229B |
| April 9, 2021 | 9.179B |
| April 8, 2021 | 9.153B |
| April 7, 2021 | 9.209B |
| April 6, 2021 | 9.256B |
| April 5, 2021 | 9.368B |
| April 1, 2021 | 9.395B |
| March 31, 2021 | 9.348B |
| March 30, 2021 | 9.378B |
| March 29, 2021 | 9.436B |
| March 26, 2021 | 9.486B |
| March 25, 2021 | 9.387B |
| March 24, 2021 | 9.221B |
| March 23, 2021 | 9.255B |
| March 22, 2021 | 9.609B |
| March 19, 2021 | 9.708B |
| March 18, 2021 | 9.554B |
| March 17, 2021 | 9.753B |
| March 16, 2021 | 9.682B |
| March 15, 2021 | 9.724B |
| March 12, 2021 | 9.436B |
| March 11, 2021 | 9.296B |
| March 10, 2021 | 9.220B |
| March 9, 2021 | 9.059B |
| March 8, 2021 | 9.091B |
| March 5, 2021 | 9.280B |
There is no data for the selected date range.
An error occurred. Please try again by refreshing your browser or contact us with details of your problem.
Advertisement
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Benchmarks
| Alkermes PLC | 3.541B |
| Iterum Therapeutics PLC | 193.47M |
| Horizon Therapeutics PLC | 21.07B |
Market Cap Range, Past 5 Years
| Minimum | 4.925B | Mar 23 2020 |
| Maximum | 11.04B | Jun 20 2018 |
| Average | 8.234B |
Market Cap Related Metrics
| PE Ratio | 19.37 |
| PS Ratio | 4.127 |
| PEG Ratio | 0.2162 |
| Price to Book Value | 2.824 |
| Price to Free Cash Flow | 13.40 |
| Price | 176.68 |
| Earnings Yield | 5.16% |
| PEGY Ratio | 0.2162 |
| Operating PE Ratio | 13.78 |
| Normalized PE Ratio | 19.33 |
News
--HC Wainwright Adjusts Price Target on Jazz Pharmaceuticals to $212 From $207, Maintains Buy Rating
MT Newswires 05/17 06:43 ET
MT Newswires 05/17 06:43 ET
Avadel to 'vigorously' defend against patent violations claims filed by Jazz
SA Breaking News 05/14 06:52 ET
SA Breaking News 05/14 06:52 ET
--UBS Adjusts Price Target on Jazz Pharmaceuticals to $236 From 228, Maintains Buy Rating
MT Newswires 05/07 10:49 ET
MT Newswires 05/07 10:49 ET
--S&P Downgrades Jazz Pharmaceuticals To 'BB-' On Elevated Leverage Following Acquisition; Outlook Stable
MT Newswires 05/05 17:44 ET
MT Newswires 05/05 17:44 ET
--RBC Boosts Price Target on Jazz Pharmaceuticals to $190 From $186, Maintains Outperform Rating
MT Newswires 05/05 08:19 ET
MT Newswires 05/05 08:19 ET
Jazz Pharmaceuticals Profit Tops Expectations on Below-Consensus Revenue, Sets In-Line FY21 Guidance
MT Newswires 05/04 16:30 ET
MT Newswires 05/04 16:30 ET
Jazz Pharmaceuticals to Participate in Three Investor Conferences in May 2021
PR Newswire 05/04 16:15 ET
PR Newswire 05/04 16:15 ET
-- GUIDANCE: (JAZZ) JAZZ PHARMACEUTICALS Expects Fiscal Year 2021 EPS Range $15.65 - $16.85
MT Newswires 05/04 16:12 ET
MT Newswires 05/04 16:12 ET
-- Earnings Flash (JAZZ) JAZZ PHARMACEUTICALS Reports Q1 EPS $3.92, vs. Street Est of $3.73
MT Newswires 05/04 16:12 ET
MT Newswires 05/04 16:12 ET
Advertisement
